In Vitro Toxicology Testing Market: By Product, By Technology, By Endpoint, By Method, By End User and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

In Vitro Toxicology Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Tissue Culture Assays, Western Blots, Cell-Based ELISA, Receptor Binding Assays), By Technology (Cellular Imaging Technology, High Throughput Technology, Toxic Genomics, Cell Culture Technology), By Endpoint (Skin Sensitization and Irritation, Cytotoxicity, Neurotoxicity, Geno Toxicity, Ocular Toxicity, Photo Toxicity, Carcinogenicity, Organ Toxicity, Dermal Toxicity), By Method (Ex Vivo Models, Cellular Assays, Biochemical Assays), By End User (Pharmaceutical Industry, Biopharmaceutical Industry, Cosmetics Industry, Household Products Industry, Chemicals Industry, Food Industry) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

In Vitro Toxicology Testing Market size was valued at US$ 8.92 billion in 2023 and is poised to grow at a CAGR of 11.0% from 2024 to 2030. The technique of determining the potential for dangerous compounds is known as in-vitro toxicity testing. It's also utilized to check for the presence of specific hazardous properties in useful substances like agricultural chemicals, therapeutic medications, and food additives. Toxicity testing is required in the development of new compounds since detecting possible toxicity earlier in the drug development process can save time and money, as well as reduce the risk of late-stage failure. In vitro, toxicology testing is used to determine whether hazardous substances or poisons are present in an organism's cells.

In vitro toxicology testing is an analysis of effects of the toxic substances on cultured mammalian cells or bacteria. These techniques are primarily employed for the identification of potentially hazardous chemicals in order to confirm certain toxic properties at the early development stages of therapeutic drugs. The market is highly fragmented due to the presence of many market players, expected to offer lucrative growth during the forecast period. Market players are concentrated on the development of new software solutions, introduction of innovative technologies, enhancing in silico simulation methods in toxicological profiling. Companies are adopting various growth strategies such as new product launches, acquisitions, and mergers in order to enhance the product portfolio and market presence.

summary download arrow Download Free Sample

In Vitro Toxicology Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

11.0%

Largest Market

North America

Fastest Growing Market

North America

In Vitro Toxicology Testing Market Dynamics

Increase in advanced technologies, rise in R&D activities in cell cultures, rise in demand for in vitro toxicology tests are expected to fuel revenue growth of in vitro toxicology testing market. Furthermore, growing awareness regarding in vitro toxicology tests, growing healthcare concern among individuals, growing economic status of developing regions are expected to offer robust growth opportunities for global market. On the other hand, stringent regulatory framework, scarcity of in vitro models to detect auto immunity and immune stimulation, technological disadvantages are restraints of the market

In Vitro Toxicology Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 8.92 billion

Market CAGR

11.0%

By Product Type

  • Bacterial Toxicity Assays,
  • Enzyme Toxicity Assays,
  • Tissue Culture Assays,
  • Western Blots,
  • Cell-Based ELISA,
  • Receptor Binding Assays

By Technology

  • Cellular Imaging Technology,
  • High Throughput Technology,
  • Toxic Genomics,
  • Cell Culture Technology

By End point

  • Skin Sensitization and Irritation,
  • Cytotoxicity,
  • Neurotoxicity,
  • Geno Toxicity,
  • Ocular Toxicity,
  • Photo Toxicity,
  • Carcinogenicity,
  • Organ Toxicity,
  • Dermal Toxicity

By Method

  • Ex Vivo Models,
  • Cellular Assays,
  • Biochemical Assays

By End User

  • Pharmaceutical Industry,
  • Biopharmaceutical Industry,
  • Cosmetics Industry,
  • Household Products Industry,
  • Chemicals Industry,
  • Food Industry

Key Features of the Report

  • The in vitro toxicology testing market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market. 
     

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global in vitro toxicology testing market size was valued at US$ 8.92 billion in 2023 and is projected to grow at a CAGR of 11.0% by 2030.

The market key players are: Cyprotex (Germany) and GE Healthcare (U.S.) Covance (U.S.) Thermo Fisher Scientific (U.S.) Eurofins Scientific SE (Luxembourg) Promega Corporation (U.S.) SGS SA (Switzerland) Merck KGaA (Germany) Lonza Group Ltd. (Switzerland) Charles River Laboratories, Inc. (U.S.)

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global In Vitro Toxicology Testing Market Introduction 
2.1.Global In Vitro Toxicology Testing Market  - Taxonomy
2.2.Global In Vitro Toxicology Testing Market  - Definitions
2.2.1. Product Type
2.2.2.Technology
2.2.3.End point
2.2.4. Method
2.2.5. End User
3.Global In Vitro Toxicology Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global In Vitro Toxicology Testing Market Analysis, 2019-2023 and Forecast 2024-2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global In Vitro Toxicology Testing Market  By By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Bacterial Toxicity Assays,
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Enzyme Toxicity Assays,
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Tissue Culture Assays,
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Western Blots,
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Cell-Based ELISA,
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Receptor Binding Assays
5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global In Vitro Toxicology Testing Market  By By Technology, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Cellular Imaging Technology,
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. High Throughput Technology,
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Toxic Genomics,
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Cell Culture Technology
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global In Vitro Toxicology Testing Market  By By End point, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Skin Sensitization and Irritation,
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cytotoxicity,
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Neurotoxicity,
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Geno Toxicity,
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Ocular Toxicity,
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Photo Toxicity,
7.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Carcinogenicity,
7.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
7.8. Organ Toxicity,
7.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.8.3. Market Opportunity Analysis 
7.9. Dermal Toxicity
7.9.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.9.3. Market Opportunity Analysis 
8.Global In Vitro Toxicology Testing Market  By By Method, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. Ex Vivo Models,
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Cellular Assays,
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Biochemical Assays
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global In Vitro Toxicology Testing Market  By By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. Pharmaceutical Industry,
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Biopharmaceutical Industry,
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Cosmetics Industry,
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Household Products Industry,
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Chemicals Industry,
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
9.6. Food Industry
9.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.6.3. Market Opportunity Analysis 
10.Pharmaceutical Industry, In Vitro Toxicology Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. By Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Bacterial Toxicity Assays,
10.1.2.Enzyme Toxicity Assays,
10.1.3.Tissue Culture Assays,
10.1.4.Western Blots,
10.1.5.Cell-Based ELISA,
10.1.6.Receptor Binding Assays
10.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cellular Imaging Technology,
10.2.2.High Throughput Technology,
10.2.3.Toxic Genomics,
10.2.4.Cell Culture Technology
10.3.  By End point Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Skin Sensitization and Irritation,
10.3.2.Cytotoxicity,
10.3.3.Neurotoxicity,
10.3.4.Geno Toxicity,
10.3.5.Ocular Toxicity,
10.3.6.Photo Toxicity,
10.3.7.Carcinogenicity,
10.3.8.Organ Toxicity,
10.3.9.Dermal Toxicity
10.4.  By Method Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Ex Vivo Models,
10.4.2.Cellular Assays,
10.4.3.Biochemical Assays
10.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Biopharmaceutical Industry, In Vitro Toxicology Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Bacterial Toxicity Assays,
11.1.2.Enzyme Toxicity Assays,
11.1.3.Tissue Culture Assays,
11.1.4.Western Blots,
11.1.5.Cell-Based ELISA,
11.1.6.Receptor Binding Assays
11.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cellular Imaging Technology,
11.2.2.High Throughput Technology,
11.2.3.Toxic Genomics,
11.2.4.Cell Culture Technology
11.3.  By End point Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Skin Sensitization and Irritation,
11.3.2.Cytotoxicity,
11.3.3.Neurotoxicity,
11.3.4.Geno Toxicity,
11.3.5.Ocular Toxicity,
11.3.6.Photo Toxicity,
11.3.7.Carcinogenicity,
11.3.8.Organ Toxicity,
11.3.9.Dermal Toxicity
11.4.  By Method Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Ex Vivo Models,
11.4.2.Cellular Assays,
11.4.3.Biochemical Assays
11.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
11.5.7.
12.Cosmetics Industry, In Vitro Toxicology Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
12.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Bacterial Toxicity Assays,
12.1.2.Enzyme Toxicity Assays,
12.1.3.Tissue Culture Assays,
12.1.4.Western Blots,
12.1.5.Cell-Based ELISA,
12.1.6.Receptor Binding Assays
12.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cellular Imaging Technology,
12.2.2.High Throughput Technology,
12.2.3.Toxic Genomics,
12.2.4.Cell Culture Technology
12.3.  By End point Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Skin Sensitization and Irritation,
12.3.2.Cytotoxicity,
12.3.3.Neurotoxicity,
12.3.4.Geno Toxicity,
12.3.5.Ocular Toxicity,
12.3.6.Photo Toxicity,
12.3.7.Carcinogenicity,
12.3.8.Organ Toxicity,
12.3.9.Dermal Toxicity
12.4.  By Method Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Ex Vivo Models,
12.4.2.Cellular Assays,
12.4.3.Biochemical Assays
12.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Household Products Industry, In Vitro Toxicology Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
13.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Bacterial Toxicity Assays,
13.1.2.Enzyme Toxicity Assays,
13.1.3.Tissue Culture Assays,
13.1.4.Western Blots,
13.1.5.Cell-Based ELISA,
13.1.6.Receptor Binding Assays
13.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cellular Imaging Technology,
13.2.2.High Throughput Technology,
13.2.3.Toxic Genomics,
13.2.4.Cell Culture Technology
13.3.  By End point Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Skin Sensitization and Irritation,
13.3.2.Cytotoxicity,
13.3.3.Neurotoxicity,
13.3.4.Geno Toxicity,
13.3.5.Ocular Toxicity,
13.3.6.Photo Toxicity,
13.3.7.Carcinogenicity,
13.3.8.Organ Toxicity,
13.3.9.Dermal Toxicity
13.4.  By Method Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Ex Vivo Models,
13.4.2.Cellular Assays,
13.4.3.Biochemical Assays
13.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Chemicals Industry, In Vitro Toxicology Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
14.1. By Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Bacterial Toxicity Assays,
14.1.2.Enzyme Toxicity Assays,
14.1.3.Tissue Culture Assays,
14.1.4.Western Blots,
14.1.5.Cell-Based ELISA,
14.1.6.Receptor Binding Assays
14.2.  By Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Cellular Imaging Technology,
14.2.2.High Throughput Technology,
14.2.3.Toxic Genomics,
14.2.4.Cell Culture Technology
14.3.  By End point Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Skin Sensitization and Irritation,
14.3.2.Cytotoxicity,
14.3.3.Neurotoxicity,
14.3.4.Geno Toxicity,
14.3.5.Ocular Toxicity,
14.3.6.Photo Toxicity,
14.3.7.Carcinogenicity,
14.3.8.Organ Toxicity,
14.3.9.Dermal Toxicity
14.4.  By Method Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Ex Vivo Models,
14.4.2.Cellular Assays,
14.4.3.Biochemical Assays
14.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Cyprotex (Germany)
15.2.2.GE Healthcare (U.S.)
15.2.3.Covance (U.S.)
15.2.4.Thermo Fisher Scientific (U.S.)
15.2.5.Eurofins Scientific SE (Luxembourg)
15.2.6.Promega Corporation (U.S.)
15.2.7.SGS SA (Switzerland)
15.2.8.Merck KGaA (Germany)
15.2.9.Lonza Group Ltd. (Switzerland)
15.2.10.Charles River Laboratories, Inc. (U.S.)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Cyprotex (Germany)
  • GE Healthcare (U.S.)
  • Covance (U.S.)
  • Thermo Fisher Scientific (U.S.)
  • Eurofins Scientific SE (Luxembourg)
  • Promega Corporation (U.S.)
  • SGS SA (Switzerland)
  • Merck KGaA (Germany)
  • Lonza Group Ltd. (Switzerland)
  • Charles River Laboratories, Inc. (U.S.)

Related Industry Reports

In Vitro Transcription Templates Market

Estonia In Vitro Diagnostics Market

Global In Vitro Toxicology Market

Global In Vitro Fertilization Market